Rhenman & Partners Asset Management’s Nurix Therapeutics NRIX Stock Holding History

Rhenman & Partners Asset Management’s Portfolio NRIX Stock Details NRIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.11M	Sell
2025 Q1	$2.96M	Sell
2024 Q4	$5.46M	Sell
2024 Q3	$6.74M	Buy
2024 Q2	$3.64M	Buy